Warm congratulations to Prof. Yihai Cao, academician of the Academia Europaea, foreign academician of the Chinese Academy of Engineering and the tenured professor of the Karolinska Institute, for publishing a heavyweight academic paper titled "Efficacy and tolerability of bevacizumab in patients with severe Covid-19" in the world's top academic journal Nature Communications.
